112 results
8-K
EX-99.1
BIOCQ
Biocept Inc
22 Aug 23
Biocept Reports Second Quarter 2023 Financial Results
4:10pm
.
Research and development (R&D) expenses for the second quarter of 2023 were $0.4 million, compared with $1.7 million for the second quarter of 2022 … and expenses:
Cost of revenues
Research and development expenses
General and administrative expenses
Sales and marketing expenses
Total costs
8-K
EX-99.1
BIOCQ
Biocept Inc
15 May 23
Biocept Reports First Quarter 2023 Financial Results
6:07am
of 2022, with the decrease primarily associated with the cessation of COVID-19 testing services.
Research and development expenses for the first quarter … and per share data)
(Unaudited)
For the Three Months Ended March 31,
Net revenues
Costs and expenses:
Cost of revenues
Research and development expenses
8-K
EX-99.1
i3itl59m y7b
17 Apr 23
Biocept Reports 2022 Financial Results
4:46pm
8-K
EX-99.1
vlc5cupo ww4cqzk3ub8
21 Nov 22
Biocept Reports Third Quarter 2022 Financial Results
4:31pm
8-K
EX-99.1
sp8ub9fuomex4er99
14 Nov 22
Biocept Reports Second Quarter 2022 Financial Results
8:01am
8-K
EX-99.1
uqbyvmf1mu15nhs4j5v0
24 May 22
Biocept Reports First Quarter 2022 Financial Results
4:01pm
8-K
EX-99.1
wgl1u9 89
7 Apr 22
Biocept Reports 2021 Fourth Quarter and Full Year Financial Results
6:05am
8-K
aljpxumkebnwarr51t
16 Feb 22
Departure of Directors or Certain Officers
4:21pm